nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A general neurologist's perspective on the urgent need to apply resilience thinking to the prevention and treatment of Alzheimer's disease
|
Pomorska, Grazyna |
|
2017 |
3 |
4 |
p. 498-506 |
artikel |
2 |
An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations
|
Sha, Sharon J. |
|
2017 |
3 |
4 |
p. 507-512 |
artikel |
3 |
A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study
|
Villemagne, Victor L. |
|
2017 |
3 |
4 |
p. 622-635 |
artikel |
4 |
Biomathematical screening of amyloid radiotracers with clinical usefulness index
|
Nai, Ying-Hwey |
|
2017 |
3 |
4 |
p. 542-552 |
artikel |
5 |
Characterization of APOE and TOMM40 allele frequencies in the Japanese population
|
Nishimura, Akira |
|
2017 |
3 |
4 |
p. 524-530 |
artikel |
6 |
Computerized cognitive training for older diabetic adults at risk of dementia: Study protocol for a randomized controlled trial
|
Bloom, Rachel |
|
2017 |
3 |
4 |
p. 636-650 |
artikel |
7 |
Concise informed consent to increase data and biospecimen access may accelerate innovative Alzheimer's disease treatments
|
Hake, Ann M. |
|
2017 |
3 |
4 |
p. 536-541 |
artikel |
8 |
Drug discovery and development: Role of basic biological research
|
Mohs, Richard C. |
|
2017 |
3 |
4 |
p. 651-657 |
artikel |
9 |
Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease
|
Zhen, Junli |
|
2017 |
3 |
4 |
p. 487-497 |
artikel |
10 |
Guide to enable health charities to increase recruitment to clinical trials on dementia
|
Chambers, Larry W. |
|
2017 |
3 |
4 |
p. 584-592 |
artikel |
11 |
Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes
|
Carnahan, Ryan M. |
|
2017 |
3 |
4 |
p. 553-561 |
artikel |
12 |
Integrating sex and gender into neurodegeneration research: A six-component strategy
|
Tierney, Mary C. |
|
2017 |
3 |
4 |
p. 660-667 |
artikel |
13 |
Measuring brain synaptic vesicle protein 2A with positron emission tomography and [18F]UCB-H
|
Bahri, Mohamed Ali |
|
2017 |
3 |
4 |
p. 481-486 |
artikel |
14 |
Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5
|
Papp, Kathryn V. |
|
2017 |
3 |
4 |
p. 668-677 |
artikel |
15 |
Potential implications of practice effects in Alzheimer's disease prevention trials
|
Jacobs, Diane M. |
|
2017 |
3 |
4 |
p. 531-535 |
artikel |
16 |
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
|
Judge, Andy |
|
2017 |
3 |
4 |
p. 612-621 |
artikel |
17 |
Proton pump inhibitors and the risk of severe cognitive impairment: The role of posttraumatic stress disorder
|
Clouston, Sean A.P. |
|
2017 |
3 |
4 |
p. 579-583 |
artikel |
18 |
Speed of processing training results in lower risk of dementia
|
Edwards, Jerri D. |
|
2017 |
3 |
4 |
p. 603-611 |
artikel |
19 |
Study protocol of the Intense Physical Activity and Cognition study: The effect of high-intensity exercise training on cognitive function in older adults
|
Brown, Belinda M. |
|
2017 |
3 |
4 |
p. 562-570 |
artikel |
20 |
Tangled tau: Active pathology or footprint of disease?
|
Higham, James P. |
|
2017 |
3 |
4 |
p. 658-659 |
artikel |
21 |
The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
|
Bertens, Daniela |
|
2017 |
3 |
4 |
p. 513-523 |
artikel |
22 |
Toward common mechanisms for risk factors in Alzheimer's syndrome
|
Medina, Miguel |
|
2017 |
3 |
4 |
p. 571-578 |
artikel |
23 |
Traumatic exposures, posttraumatic stress disorder, and cognitive functioning in World Trade Center responders
|
Clouston, Sean A.P. |
|
2017 |
3 |
4 |
p. 593-602 |
artikel |